Lecture 1: Technology Assessment and Health Data Flashcards

1
Q

Material Nature Groups

A
  • Drugs
  • Biologics
  • Devices, equipment, and supplies
  • Medical/Surgical procedures
  • Support System
  • Organizational and Managerial Systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Purpose and Application Groups

A
  • Prevention
  • Screening
  • Diagnosing
  • Treating
  • Rehabilitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tech Purpose - Prevention

A

Health interventions designed to prevent a patient from developing a disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tech Purpose - Screening

A

A test given to members of a defined population, not necessarily at rick, to identify individuals who would benefit by further testing for diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tech Purpose - Diagnosing

A

Identification of a disease through, signs, symptoms, imaging, and various biochemical markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tech Purpose - Treating

A

Intervention to cure or reduce symptoms of a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tech Purpose - Rehabilitation

A

Process of restoring skills lost to illness or injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Health Technology Assessment

A

Is a multidisciplinary field of policy analysis. It studies the
medical, social, ethical, and economic implications of
development, diffusion, and use of health technology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patient and Societal Outcomes

A
  • Direct and indirect effects
  • Efficacy
  • Effectiveness
  • Safety
  • Ethical concerns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Who uses HTA?

A
  • Health product makers
  • Regulators
  • Clinicians
  • Patients
  • Hospitals
  • Managers
  • Government Leaders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

US Preventative Task Forces

A

Makes recommendations about clinical preventive services. Has Grades A-D and I Statement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What type of data is gathered for an HTA?

A
  • Data on the population
  • Vital statistics
  • Health statistics
  • Statistics about helath services
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the 2 types of Epimemiologic Studies

A
  • Experimental (Randomized Clinical Trials)

- Observational

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is an Experimental Epidemiological Study?

A

– Takes two populations with similar conditions and randomly,
and blindly assigns one group a new “treatment” and the
other a placebo or standard care. Used to determine causation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an Observational Epidemiological Study?

A

– Looks at two populations that had been previously assigned a
control vs. treatment group and assesses the differences
between the groups over time. Gives correlations or associations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When do you use an Observational Study?

A
  • Ethical concerns
  • When study parameters may be rare, or difficult to cause
  • When researches do not have a control
17
Q

What can an Observational Study do?

A
  • Provide indications of benefits and risk

- Give motivation to o controlled randomized experiments

18
Q

What are the limitations of an Observational Study?

A
  • Cannot make statements about safety, efficacy, or effectiveness
  • Cannot determine causes
  • Can have bias0some things end up not reported, people receiving the “treatment” is not random
19
Q

Longitudinal Observational Study

A

Follows individuals over time to track changes with the same variable, repeated observation, can be retroactive.

20
Q

Cross-sectional Observational Study

A

Describes feature of population such as prevalence of illness, relative risk and association

21
Q

Association

A

Statistical dependence between two or more events

22
Q

Relative Risk (RR)

A

Asses the strength of an association.
RR = 1 no risk,
RR > 1 means increased risk
RR < 1 means protective effect

23
Q

Incidence

A

Number of new cases of disease in a population over a period of time

Annual Incidence Rate = # of new cases (in 1 year)/# in that population (at mid year)

24
Q

Prevalence

A

Number of existing cases of the disease in a population at a given time

Point Prevalence = # of total cases at one time/ # in that population at same time point

25
Mortality Rate
Number of deaths - Specific for disease Mortality Rate = # of deaths in a defines population/ # in that population mid year (can be adapted for a subset population - Infant Mortality Rate)
26
Morbidity
- Degree or severity of disease | - Hard to define
27
Disability-Adjusted Life Year (DALY)
- Years of life lost due to ill health, disability, or premature death - Measure overall disease burden (combines mortality and morbidity)
28
DALY = YYL + YLD
Years of Life Lost = life expectancy - age of death | Years Lost to Disability = duration of disability x disability weight
29
Developed Country
Has a higher standard of living and diversified economy
30
Developing Country
Low per capital income and a Lower Human Development Index (Education, Health, Income)
31
Purchasing Power Parity
Convert currencies based upon an equivalent basket of good and services
32
What is the criteria for Least Developed Country (LDC)
- GDP per capita $900 to graduate - Human resource weakness - Economic vulnerabiltiy
33
Disparcity
Inequality, large differences
34
What are indicators of disparity?
- Avg. annual per capital health expenditure - Low Human Development Index (HDI) Burden of disease (DALYs) - Infant mortality rate
35
What are some of the health risk in an informal settlement?
- Sanitation (cholera and other diarrheal diseases)
36
Sensitivity (Se)
Given DISEASE, screening test is POSITIVE. Able to correctly detect disease. Se = TP/(# with disease)
37
Specificity (Sp)
Given NO DISEASE, screening test is NEGATIVE. Ability to avoid calling normal things disease Se = TN/(# without disease)
38
Positive Prevalence Value (PPV)
Probability that given a positive test result, you have DISEASE PPV = TP/(TP+FP)
39
Negatieve Prevalence Value (NPV)
Probability that given a NEGATIVE test result, you do NOT HAVE DISEASE NPV = TN/(TN+FN)